How to Help Your Patients Find Lomaira in Stock: A Provider's Guide

"My pharmacy doesn't carry Lomaira" and "I called three places and no one has it" are among the most common messages that obesity medicine and primary care practices receive from patients on Lomaira (phentermine hydrochloride 8 mg). While Lomaira is not in an official FDA shortage, its status as a brand-name Schedule IV controlled substance with no generic equivalent creates real, persistent dispensing friction. This guide gives your clinical and administrative team a concrete playbook for reducing that friction — from workflow adjustments at the point of prescribing to patient-facing resources.

Understanding Why Patients Can't Fill Lomaira

Helping patients effectively starts with understanding the root causes. Lomaira availability challenges are driven by:

• No generic equivalent: The 8 mg phentermine dose is brand-only. Pharmacies that don't stock Lomaira specifically cannot substitute a generic.
• Schedule IV ordering limits: DEA controls on controlled substances limit how much phentermine a pharmacy can order, and how often.
• Variable stocking by pharmacy: Each pharmacy decides whether to stock Lomaira based on local demand. A pharmacy that rarely sees Lomaira prescriptions may not order it at all.

Workflow Tip 1: Direct Prescriptions to Known-Carrying Pharmacies

One of the highest-impact changes your practice can make is to identify one or two local pharmacies that reliably stock Lomaira and direct patients there by default. Call your area's independent pharmacies and a few chains to confirm who stocks it. Maintain a short list in your EHR or at the front desk, and update it quarterly. When issuing a new Lomaira prescription, ask the patient which pharmacy to send it to before electronically prescribing — send it only after the patient confirms the pharmacy has it in stock.

Workflow Tip 2: Write for 90-Day Supplies Where Permitted

For established patients doing well on Lomaira, writing for 90-day supplies (where permitted by your state's controlled substance regulations) reduces the frequency with which patients need to locate stock. This is particularly helpful for patients in rural or suburban areas with limited pharmacy access. Check your state's DEA and pharmacy board guidelines — most states allow 90-day supplies for Schedule IV controlled substances.

Workflow Tip 3: Clearly Mark Prescriptions as Brand-Necessary

Since there is no generic 8 mg phentermine, some pharmacies may be confused when processing a Lomaira prescription. Clearly specifying "Lomaira (phentermine HCl 8 mg tablets, KVK Tech) — dispense as written" on the prescription eliminates substitution confusion and sends a clear signal to the pharmacy that the specific brand and dose are required.

Patient Education: What to Tell Patients at the Point of Prescribing

Setting expectations at the time of prescribing reduces patient frustration significantly. Key points to communicate:

• Lomaira is a brand-name product with no generic — not every pharmacy carries it, but it can usually be ordered within 1–2 business days
• Patients should call their pharmacy before the prescription is sent to confirm stock — this prevents a prescription from getting "stuck" at a pharmacy that doesn't carry it
• If the pharmacy doesn't have it, patients should ask about ordering — not just assume it's unavailable everywhere
• Mid-month, Tuesday–Thursday filling gives the best chances of finding controlled substance stock

Recommend medfinder for Patients Who Can't Locate Stock

For patients who are having persistent difficulty locating Lomaira, medfinder is a paid service that contacts pharmacies near the patient's location to find which ones can fill the prescription. Patients submit their medication, dose, and zip code, and receive pharmacy availability results via text. This can save patients — and your staff — significant time otherwise spent on hold.

When to Consider Switching to an Alternative

Not every patient who struggles to find Lomaira should be switched to an alternative — for many, the 8 mg TID dosing is clinically preferable. But certain situations do warrant a conversation about alternatives:

• Patient has been unable to fill for more than 1–2 weeks and has no viable pharmacy option
• Patient's weight management goals would benefit from a longer-term, FDA-approved option (consider Qsymia or Contrave)
• Patient is tolerating Lomaira well but finds the 3x-daily regimen burdensome — generic phentermine 37.5 mg once daily may be a simpler alternative
• Patient requests a GLP-1 transition — discuss clinical eligibility, injection requirements, and cost implications

Savings Resources to Share With Patients

Many patients on Lomaira are cost-sensitive. Key savings resources to communicate at prescribing:

• Lomaira Lo-Cost Access Program (KVK Tech): No more than $0.50 per tablet for the duration of treatment. Patients register at lomaira.com/money-saving-offer/. This can reduce cost to approximately $15 for 30 tablets or $45 for 90 tablets.
• GoodRx: As low as $17 for 30 tablets at participating pharmacies. Note: phentermine is a controlled substance and some states do not allow discount cards on controlled substance prescriptions.
• SingleCare: ~$26 for 30 tablets with SingleCare savings card.

Summary: Your Practice's Lomaira Availability Playbook

1. Maintain a short list of local pharmacies confirmed to stock Lomaira
2. Ask patients to confirm pharmacy stock before sending the prescription electronically
3. Write 90-day supplies for established patients where state law permits
4. Mark prescriptions clearly as brand-only (Lomaira, 8 mg, KVK Tech)
5. Recommend medfinder for patients experiencing persistent difficulty locating stock
6. Share the Lomaira Lo-Cost Access Program with all new Lomaira patients
7. Have a documented alternative prescribing plan for when Lomaira is not accessible

For more clinical background on the Lomaira availability situation, see our post: Lomaira shortage: what providers and prescribers need to know in 2026